Innovaderm is following Health Canada and Centers for Disease Control (CDC) guidance and is recommending to all CRO Operations employees able to work from home to do so immediately until further notice. Where possible, public transit, air and rail travel will be discouraged in regions with known outbreaks.


Innovaderm will continue to review our business continuity plan and adjust as needed. Further updates and information about Innovaderm’s response to COVID-19 will be shared on this webpage.

For COVID-19 criteria, visit the following websites:


NEW!! FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic:

Health Canada: